-
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from Brokerages
Source: Buzz FX / 09 Jan 2025 06:56:14 America/Chicago
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat January 9, 2025 Share Link copied to clipboard. LENZ Therapeutics, Inc. ( NASDAQ:LENZ - Get Free Report ) has received a consensus
Read more...